Navigation Links
DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
Date:1/31/2008

CUPERTINO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2007 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

When: Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

Where: Live over the Internet -- Simply log on to http://www.durect.com,

and then click 'Investor Relations' and then 'Events Calendar.'

Webcast

Link: http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-calendar

If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. DURECT to Host Webcast in Conjunction with an Analysts Day on October 17
2. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
3. Baxa Corporation Launches New Web Site
4. CuraGen Corporation Receives Notification from NASDAQ
5. Healionics Corporation Completes Series A Financing
6. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
7. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
8. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
9. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
10. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
11. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ... value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic ... Symposium. Using molecular test results from tumors with previously documented positive, negative, ...
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will build ... popularity of US Single Day Events (SDE) to organize a multiple-day US conference. ... Raleigh, NC. Topics of the pharmaceutical and life sciences industry will cover industry ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only ... a beautiful technology experience. All three tenets were on display at the 2nd Annual ... from over 40 sponsor, CRO and site organizations to discuss innovation and the future ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved chemistry, ... in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
Breaking Biology Technology:
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):